Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects

E-ISSN： 1873-4286|21|24|3548-3556

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.24, 2015-01, pp. : 3548-3556

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview

By Semeraro Francesco Morescalchi Francesco Duse Sarah Gambicorti Elena Romano Mario R Costagliola Ciro

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 785-802

Informa Healthcare

Access to resources Recommend Favorite

Anti-VEGF Therapy for Retinal Vein Occlusions

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 328-336

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection

Current Drug Metabolism, Vol. 16, Iss. 7, 2015-09 ,pp. : 572-584

Bentham Science Publishers

Access to resources Recommend Favorite

Resistance to Anti-VEGF Agents

Current Pharmaceutical Design, Vol. 10, Iss. 1, 2004-01 ,pp. : 51-64

Bentham Science Publishers

Access to resources Recommend Favorite

Inhaled corticosteroids in COPD: systemic effects of a local therapy?

By Antoniu Sabina A

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3271-3273

Informa Healthcare

Access to resources Recommend Favorite